HUMAN INTERFERON-BETA - EFFECTS OF DEGLYCOSYLATION

被引：35
|
作者：
KNIGHT, E
FAHEY, D
机构：
来源：
JOURNAL OF INTERFERON RESEARCH | 1982年 / 2卷 / 03期
关键词：
D O I：
10.1089/jir.1982.2.421
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：421 / 429
页数：9
相关论文
共 50 条
  • [1] TACRINE AND HUMAN INTERFERON-BETA
    AHMAD, SR
    LANCET, 1993, 341 (8848): : 820 - 820
  • [2] EFFECTS OF HUMAN INTERFERON-BETA ON PRIMARY HEPATIC CANCER
    KATO, Y
    HINOUE, Y
    KOBAYASHI, K
    HATTORI, N
    KOBAYASHI, S
    HEPATOLOGY, 1982, 2 (05) : 736 - 736
  • [3] SUPERINDUCTION OF THE HUMAN INTERFERON-BETA PROMOTER
    DINTER, H
    HAUSER, H
    EMBO JOURNAL, 1987, 6 (03): : 599 - 604
  • [4] IN-VITRO EFFECTS OF INTERFERON-BETA ON HUMAN CNS CELLS
    YONG, VW
    ANTEL, JP
    WILLIAMS, K
    NEUROLOGY, 1994, 44 (04) : A212 - A212
  • [5] PROCESSING OF RECOMBINANT HUMAN INTERFERON-BETA
    FRAUNE, E
    KULA, MR
    LEHMANN, J
    MENGE, U
    SCHUGERL, K
    CHEMIE INGENIEUR TECHNIK, 1986, 58 (09) : 768 - 768
  • [6] PHARMACOKINETICS OF HUMAN INTERFERON-BETA IN MONKEYS
    HILFENHAUS, J
    DAMM, H
    HOFSTAETTER, T
    MAULER, R
    RONNEBERGER, H
    WEINMANN, E
    JOURNAL OF INTERFERON RESEARCH, 1981, 1 (03): : 427 - 436
  • [7] CHARACTERIZATION OF E-COLI-DERIVED RECOMBINANT HUMAN INTERFERON-BETA AS COMPARED WITH FIBROBLAST HUMAN INTERFERON-BETA
    UTSUMI, J
    YAMAZAKI, S
    HOSOI, K
    KIMURA, S
    HANADA, K
    SHIMAZU, T
    SHIMIZU, H
    JOURNAL OF BIOCHEMISTRY, 1987, 101 (05): : 1199 - 1208
  • [8] Effects of interferon-beta on oligodendroglial cells
    Heine, Sandra
    Ebnet, Jens
    Maysami, Sarnaneh
    Stangel, Martin
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 177 (1-2) : 173 - 180
  • [9] INTERFERON-BETA - BIOLOGICAL AND CLINICAL EFFECTS
    BORDEN, EC
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (02): : 216 - 217
  • [10] Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta
    Gilli, Francesca
    De la Torre, Adrianna L.
    Royce, Darlene B.
    Pachner, Andrew R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 1 - 6
12345